Clinical Trials
67 trialsOvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
iCaRe2
University of Nebraska
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
TraveraRTGx
Travera Inc
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
ASAP
Avera McKennan Hospital & University Health Center
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
EXoPERT EMERALD Clinical Study
EXoPERT
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
IMPLICATION
Centre Hospitalier Universitaire de Besancon
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
K-ACCELERATE
Gene Solutions
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Instituto de Investigacion Sanitaria La Fe
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
ROOT
Taproot Health
VCV
Mitera Hospital
QUANTUM
VitaMed Research LLC
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
WWE
UNC Lineberger Comprehensive Cancer Center
TUM-DC
University of Milano Bicocca
Physician Use of Non-English Language Skills in Cancer Care
Memorial Sloan Kettering Cancer Center
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Biologics & Biosimilars Collective Intelligence Consortium
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Eastern Cooperative Oncology Group
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Eastern Cooperative Oncology Group
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
SWOG Cancer Research Network
ARIES
Genentech, Inc.
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Kazakh Medical University of Continuing Education
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients
Seoul National University Hospital
Whole-Exome Sequencing (WES) of Cancer Patients
Dana-Farber Cancer Institute
PIONEER
SpeciCare
Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs
National Institutes of Health Clinical Center (CC)
Testing a Spanish Version of a Patient Toxicity Questionnaire
National Institutes of Health Clinical Center (CC)
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences